Background Currently, only a fraction of patients with non-small cell lung cancer (NSCLC)
treated with immune checkpoint inhibitors (ICIs) experience a durable clinical benefit (DCB). …

OBJECTIVE An analysis of factors contributing to durable radiographic control of spinal
metastases was undertaken, drawing from a large single-institution database in an attempt to …

Importance Even though 15% to 50% of patients with head and neck squamous cell carcinoma
(HNSCC) experience recurrence, relatively little is known regarding patterns of treatment …

Importance Prostate cancer (PCa) disproportionately affects African American men, but research
evaluating the extent of racial and ethnic disparities across the PCa continuum in equal-…

Purpose To characterize local tumor control and toxicity risk in very long-term survivors (>5
years) after high-dose spinal image guided, intensity modulated radiation therapy delivered …

Background Approximately 50% of cancer patients eventually develop a syndrome of
prolonged weight loss (cachexia), which may contribute to primary resistance to immune …

PURPOSE Prostate cancer (PCa) is among the leading causes of cancer deaths. While
localized PCa has a 5-year survival rate approaching 100%, this rate drops to 31% for metastatic …

Background Personalized genomic classifiers have transformed the management of
prostate cancer (PCa) by identifying the most aggressive subsets of PCa. Nevertheless, the …

Background Immunotherapy yields survival benefit for some advanced stage non-small cell
lung cancer (NSCLC) patients. Because highly predictive biomarkers of immunotherapy …

Objective: To determine whether hydronephrosis is an independent prognostic indicator of
survival among patients with advanced cervical carcinoma. Moreover, we wanted to …